Item 7.01 Regulation FD Disclosure.
On January 21, 2021, Heron Therapeutics, Inc. issued a press release announcing
that the results from an EPOCH 1 follow-on study (NCT03718039) of the
investigational agent HTX-011 in bunionectomy, have been published online, by
the Journal of the American Podiatric Medical Association in an article entitled
"Opioid-Free Recovery from Bunionectomy with HTX-011, a Dual-Acting Local
Anesthetic Combining Bupivacaine and Meloxicam, as the Foundation of Non-Opioid
Multimodal Analgesia," as described in the press release furnished herewith as
Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release, dated January 21, 2021
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses